Compare AMRX & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMRX | NMRK |
|---|---|---|
| Founded | 2002 | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.2B |
| IPO Year | 2018 | 2017 |
| Metric | AMRX | NMRK |
|---|---|---|
| Price | $13.20 | $14.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $14.75 | ★ $18.80 |
| AVG Volume (30 Days) | 1.6M | ★ 1.8M |
| Earning Date | 05-15-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 0.84% |
| EPS Growth | ★ 157.89 | 100.00 |
| EPS | 0.22 | ★ 0.68 |
| Revenue | N/A | ★ $3,294,024,000.00 |
| Revenue This Year | $6.40 | $13.05 |
| Revenue Next Year | $6.54 | $7.68 |
| P/E Ratio | $60.25 | ★ $20.93 |
| Revenue Growth | N/A | ★ 20.29 |
| 52 Week Low | $6.69 | $9.65 |
| 52 Week High | $15.42 | $19.84 |
| Indicator | AMRX | NMRK |
|---|---|---|
| Relative Strength Index (RSI) | 34.52 | 42.43 |
| Support Level | $12.50 | $13.36 |
| Resistance Level | $13.49 | $18.00 |
| Average True Range (ATR) | 0.42 | 0.67 |
| MACD | -0.21 | 0.04 |
| Stochastic Oscillator | 14.89 | 47.70 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.